Skip to main content

Table 2 Intergroup comparison for dialysis patients according to CAC level at baseline ( n= 65)

From: Relationship between sclerostin and cardiovascular calcification in hemodialysis patients: a cross-sectional study

  

CAC <100

CAC >100 (65%)

N

[n, (%)]

23 (35%)

42 (65%)

Gender (male)

[n, (%)]

10 (45%)

21 (50%)

Age

[yrs]

51 ± 16

64 ± 12

Time since first dialysis [mo]

 

87 ± 88

64 ± 68

BMI

[kg/m2]

26 ± 7

25 ± 5

CAC Agatston

28 ± 35

1014 ± 907

 

AVC Agatson

14 ± 35

88 ± 266

 

ucMGP

[nmol/L]

2199 ± 714

2423 ± 725

Fetuin-A

[g/L]

0.47 ± 0.12

0.45 ± 0.08

OPG

[pmol/L]

4.13 ± 2.62

5.95 ± 2.53

Sclerostin

[ng/mL]

1.52 ± 0.71

1.54 ± 0.86

CRP

[mg/L]

4.19 ± 6.35

8.05 ± 6.67

iPTH

[pg/mL]

119 ± 139

282 ± 396

BAP

[U/L]

29 ± 22

33 ± 28

AP

[U/L]

82 ± 46

89 ± 72

Total Ca2+

[mmol/L]

2.25 ±0.27

2.39 ± 0.29

Phosphorus

[mmol/L]

1.77 ± 0.53

1.83 ± 0.50

Albumin

[g/L]

39 ± 8

39 ± 4

Haemoglobin

[g/L]

109 ± 14

109 ± 27

S-Creatinine

[mg/dL]

9.7 ± 3.2

9.1 ± 2.6

S-Urea

[mmol/L]

82 ± 60

62 ± 61